(Q36085865)

12 August 2017

1 reference

title

Mycophenolate mofetil and neurological diseases (English)

1 reference

12 August 2017

P Vermersch

1

1 reference

PubMed ID

15803931

12 August 2017

T Stojkovic

series ordinal

2

1 reference

PubMed ID

15803931

12 August 2017

J de Seze

series ordinal

3

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

14 Suppl 1

1 reference

12 August 2017

s42-5

1 reference

Mechanisms of action of mycophenolate mofetil

12 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate in treatment-resistant inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Inflammatory myopathies: clinical, diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate-mofetil in the treatment of refractory multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

Mycophenolate mofetil in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2117OA

10.1191/0961203305LU2117OA

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15803931